Entry comments: FDA Approval for the smallest pacemaker came out just before the bell. Goal is to sell into strength at the open for $2+ per share gain.
000
Date
Price
Entry
4/6/2016
77.31
Total Views59
Position Size100
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only: